H0P-MC-OA03 - ClinicalTrials.gov - NCT04627038
H0P-MC-OA03 - ClinicalTrials.gov - NCT04627038
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have a body mass index <40 kilograms per meter squared (kg/m2)
Participants must be willing to maintain any non-drug pain relieving therapies (for example, physical therapy) and not start any new non-drug pain-relieving therapies during the study
Participants must be willing to stop all pain medications for osteoarthritis, except for rescue medication allowed in the study
Participants must have index knee pain for at least 12 weeks
Participants must NOT
Participants must not have had a procedure within the past 6 months intended to produce permanent sensory loss in the target area of interest (for example, ablation techniques)
Participants must not have surgery planned during the study for any reason
Participants must not have had cancer within 2 years, except for certain types of skin cancer (cutaneous basal cell or squamous cell carcinoma) surgically removed
Participants must not have an intolerance to acetaminophen or paracetamol
Participants must not have an unstable index joint (such as a torn anterior cruciate ligament), surgical hardware or have had a surgical procedure or therapeutic injection in the affected knee within 3 months
Trial Summary
Conditions the trial is for
Osteoarthritis
What the trial is testing?
LY3556050
Could I receive a Placebo?
yes
Enrollment Goal
150
Trial Dates
November 2020 - July 2021
Trial Phase
2
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have a body mass index <40 kilograms per meter squared (kg/m2)
Participants must be willing to maintain any non-drug pain relieving therapies (for example, physical therapy) and not start any new non-drug pain-relieving therapies during the study
Participants must be willing to stop all pain medications for osteoarthritis, except for rescue medication allowed in the study
Participants must have index knee pain for at least 12 weeks
Participants must NOT
Participants must not have had a procedure within the past 6 months intended to produce permanent sensory loss in the target area of interest (for example, ablation techniques)
Participants must not have surgery planned during the study for any reason
Participants must not have had cancer within 2 years, except for certain types of skin cancer (cutaneous basal cell or squamous cell carcinoma) surgically removed
Participants must not have an intolerance to acetaminophen or paracetamol
Participants must not have an unstable index joint (such as a torn anterior cruciate ligament), surgical hardware or have had a surgical procedure or therapeutic injection in the affected knee within 3 months
Trial Summary
Conditions the trial is for
Osteoarthritis
What the trial is testing?
LY3556050
Could I receive a Placebo?
yes
Enrollment Goal
150
Trial Dates
November 2020 - July 2021
Trial Phase
2
Trial Locations
Hide locations not currently recruiting